MiR-630 suppresses breast cancer progression by targeting metadherin.
Zhou CX, Wang CL, Yu AL, Wang QY, Zhan MN, Tang J, Gong XF, Yin QQ, He M, He JR, Chen GQ, Zhao Q.
Zhou CX, et al. Among authors: gong xf.
Oncotarget. 2016 Jan 12;7(2):1288-99. doi: 10.18632/oncotarget.6339.
Oncotarget. 2016.
PMID: 26595523
Free PMC article.